The uterine manipulator devices market is expected to witness a CAGR of 5.8% during the study period, 2022-2027.
The world has been facing the huge threat of COVID-19. As per the World Health Organization (WHO), COVID-19 is infectious, and most people infected by the virus experience mild to moderate respiratory illness. In the early phase of the pandemic, due to the increasing cases of COVID-19, all hospitals globally had canceled their scheduled and elective surgeries. Acute surgical emergencies were still inevitable and were being addressed in a timely and sensible manner. Severe cases of gynecological laparoscopy surgeries were being conducted during the peak COVID-19 times. According to the report published by the British Journal of Surgery, in May 2020, an estimated 585,000 elective surgeries were postponed in the 12-week lockdown in India alone, and 28.4 million elective surgeries worldwide were canceled or postponed. Thus, the halt of surgical procedures has affected the number of hysterectomy procedures, thereby acting as the major factor that hampered the uterine manipulation devices market.
According to the study “COVID-19 pandemic and gynecological laparoscopic surgery: knowns and unknowns,” published in April 2020, urgent gynecological and cancer procedures were continuing during the peak of the pandemic. However, the concerns relating to the transmission of COVID-19 during gynecological laparoscopic surgery arising from the potential generation of SARS-CoV-2 contaminated aerosols from CO2 leakage and the creation of smoke from the use of energy devices were high. This has impacted the number of gynecological laparoscopic surgery procedures held, and asymptomatic patients were prioritized, significantly impacting the market growth.
Another study, “Influence of COVID-19 in Selection of Route of Hysterectomy in Benign Disease,” published in November 2021, indicated that during the second wave of the pandemic, the number of hysterectomy procedures performed doubled as compared to the first peak, thus driving the demand for the market. Thus, COVID-19 has impacted the studied market in terms of supply chain disruptions and postponement of nonelective surgeries. However, as the COVID-19 conditions ease out, the market will grow significantly.
The factors propelling the studied market growth are the growing burden of diseases related to the female reproductive system, increasing technological advancements, and rising demand for minimally invasive surgical procedures.
Common diseases related to the female reproductive system are endometriosis, cervical cancer, uterine fibroids, interstitial cytosis, and polycystic ovary syndrome, among others. According to February 2022 update by World Health Organization, cervical cancer is the fourth most common cancer among women globally, with an estimated 604,000 new cases and 342,000 deaths in 2020. About 90% of the new cases and deaths worldwide in 2020 occurred in low- and middle-income countries.
According to an article published by endometriosis.org in March 2021, endometriosis affects an estimated 1 in 10 women during their reproductive years, usually between the ages of 15 to 49, which is approximately 176 million women in the world. Thus, the high prevalence of endometriosis will increase the demand for hysterectomy procedures, thereby driving the demand for uterine manipulation devices, thus propelling the market growth.
Additionally, the research and development procedures establishing the efficacies of the intrauterine manipulator will increase its adoption, thereby contributing to the significant growth of the market. For instance, the study “Uterine manipulator in total laparoscopic hysterectomy: safety and usefulness,” published in December 2020, suggested that uterine manipulator provides support in cases of large uteri, severe endometriosis, recto vaginal adhesions, and regional anesthesia. Thus, the expanded scope of these devices will increase their adoptability, thus driving the market.
Total Laparoscopic Hysterectomy (TLH) is the removal of the uterus and cervix through four small (1/2’- 1’) abdominal incisions. This procedure may also include the removal of the ovaries and tubes, depending on the patient. TLH is performed to treat the disease of the uterus, such as fibroids, pelvic pain infection in ovaries and vaginal tubes, abnormal vaginal bleeding, and others. The factors such as the growing burden of these diseases and growing research and development studies are expected to boost the market growth.
According to an article published by Office on Women’s Health in April 2019, approximately 20 percent to 80 percent of women develop fibroids by the time they reach age 50 in the United States. Fibroids are most common in women in their 40s and early 50s. The high prevalence of fibroids among women in the United States increases the hysteroscopy procedures and uterine manipulators, as that is used in these procedures, thus driving the market.
Additionally, rising research studies proving the efficacy and safety of using uterine manipulators during TLH procedures will increase its adaptability, which will also contribute to market growth. For instance, according to the study “Total laparoscopic hysterectomy with a newly designed uterine manipulator (Halder’s): Safety, efficacy and perforation prevention ” published in April 2020, the Halder’s uterine manipulator is an easy, smart and simple option to do TLH, which reduces the complications and have more favorable operative outcomes. This manipulator can be used by inexperienced persons at the vaginal end, thus, positively impacting the market growth.
The study “Laparoendoscopic Single Site Hysterectomy: Literature Review and Procedure Description,” published in April 2021, suggests that intra-uterine manipulator permits a better exposure of the pelvic field, helping the surgeon by exposing the correct surgical planes of the operative field. Thus, added advantages of uterine manipulators during TLH procedures will fuel the market growth.
The primary driving factors for the growth of the North American uterine manipulator market are the rising burden of female reproductive system diseases such as cervical cancer, endometriosis, and others, rising demand for minimally invasive surgeries, and rising technological advancements.
The United States within North America contributes to the significant growth in the studied market. The rising burden of these diseases in the country will boost the market. For instance, according to a January 2022 update by the American Cancer Society, approximately 14,100 new cases of invasive cervical cancer will be diagnosed in 2022 in the country, with estimated 4,280 women deaths from the disease. Thus, the high prevalence and mortality rate associated with cervical cancer will boost its early treatment, thereby driving the demand for uterine manipulator devices as they are used for addressing cervical cancer, thus boosting the market.
The rising research and development studies in the market will also boost market growth. For instance, a prospective, multicenter, randomized non-inferiority phase III study was initiated in May 2021 to evaluate if patients undergoing a minimally invasive surgery for early-stage uterine cancer have cancer cells in the fluid that is obtained at the time of their surgery when a uterine manipulator is placed versus patients who do not have a uterine manipulator placed. Such studies will help in evaluating the efficacy and safety of the uterine manipulators, which can boost their adaptability; therefore, such studies might contribute to the market growth.
The article “For Early-Stage Cervical Cancer, Minimally Invasive Surgery Declining,” published by National Cancer Institute in May 2021, suggested that uterine manipulators are used during minimally invasive procedures to improve the surgeon’s ability to access and visualize the uterus and surrounding structures. Thus, as uterine manipulators assist surgeons during minimally invasive surgeries, the demand for the same is expected to grow during the study period, which will propel the market growth.
The major players in the market are Conkin Surgical Instrument Ltd., CooperSurgical Inc., B. Braun Melsungen AG, KARL STORZ GmbH & Co. KG, CONMED Corporation, and others.
This product will be delivered within 2 business days.
The world has been facing the huge threat of COVID-19. As per the World Health Organization (WHO), COVID-19 is infectious, and most people infected by the virus experience mild to moderate respiratory illness. In the early phase of the pandemic, due to the increasing cases of COVID-19, all hospitals globally had canceled their scheduled and elective surgeries. Acute surgical emergencies were still inevitable and were being addressed in a timely and sensible manner. Severe cases of gynecological laparoscopy surgeries were being conducted during the peak COVID-19 times. According to the report published by the British Journal of Surgery, in May 2020, an estimated 585,000 elective surgeries were postponed in the 12-week lockdown in India alone, and 28.4 million elective surgeries worldwide were canceled or postponed. Thus, the halt of surgical procedures has affected the number of hysterectomy procedures, thereby acting as the major factor that hampered the uterine manipulation devices market.
According to the study “COVID-19 pandemic and gynecological laparoscopic surgery: knowns and unknowns,” published in April 2020, urgent gynecological and cancer procedures were continuing during the peak of the pandemic. However, the concerns relating to the transmission of COVID-19 during gynecological laparoscopic surgery arising from the potential generation of SARS-CoV-2 contaminated aerosols from CO2 leakage and the creation of smoke from the use of energy devices were high. This has impacted the number of gynecological laparoscopic surgery procedures held, and asymptomatic patients were prioritized, significantly impacting the market growth.
Another study, “Influence of COVID-19 in Selection of Route of Hysterectomy in Benign Disease,” published in November 2021, indicated that during the second wave of the pandemic, the number of hysterectomy procedures performed doubled as compared to the first peak, thus driving the demand for the market. Thus, COVID-19 has impacted the studied market in terms of supply chain disruptions and postponement of nonelective surgeries. However, as the COVID-19 conditions ease out, the market will grow significantly.
The factors propelling the studied market growth are the growing burden of diseases related to the female reproductive system, increasing technological advancements, and rising demand for minimally invasive surgical procedures.
Common diseases related to the female reproductive system are endometriosis, cervical cancer, uterine fibroids, interstitial cytosis, and polycystic ovary syndrome, among others. According to February 2022 update by World Health Organization, cervical cancer is the fourth most common cancer among women globally, with an estimated 604,000 new cases and 342,000 deaths in 2020. About 90% of the new cases and deaths worldwide in 2020 occurred in low- and middle-income countries.
According to an article published by endometriosis.org in March 2021, endometriosis affects an estimated 1 in 10 women during their reproductive years, usually between the ages of 15 to 49, which is approximately 176 million women in the world. Thus, the high prevalence of endometriosis will increase the demand for hysterectomy procedures, thereby driving the demand for uterine manipulation devices, thus propelling the market growth.
Additionally, the research and development procedures establishing the efficacies of the intrauterine manipulator will increase its adoption, thereby contributing to the significant growth of the market. For instance, the study “Uterine manipulator in total laparoscopic hysterectomy: safety and usefulness,” published in December 2020, suggested that uterine manipulator provides support in cases of large uteri, severe endometriosis, recto vaginal adhesions, and regional anesthesia. Thus, the expanded scope of these devices will increase their adoptability, thus driving the market.
Key Highlights
- However, some of these devices and stringent regulations regarding product approvals are expected to restrain the market growth during the study period.
Key Market Trends
Total Laproscopic Hysterectomy Segment is Expected to Account for the Largest Market Share During the Forecast Period
Total Laparoscopic Hysterectomy (TLH) is the removal of the uterus and cervix through four small (1/2’- 1’) abdominal incisions. This procedure may also include the removal of the ovaries and tubes, depending on the patient. TLH is performed to treat the disease of the uterus, such as fibroids, pelvic pain infection in ovaries and vaginal tubes, abnormal vaginal bleeding, and others. The factors such as the growing burden of these diseases and growing research and development studies are expected to boost the market growth.
According to an article published by Office on Women’s Health in April 2019, approximately 20 percent to 80 percent of women develop fibroids by the time they reach age 50 in the United States. Fibroids are most common in women in their 40s and early 50s. The high prevalence of fibroids among women in the United States increases the hysteroscopy procedures and uterine manipulators, as that is used in these procedures, thus driving the market.
Additionally, rising research studies proving the efficacy and safety of using uterine manipulators during TLH procedures will increase its adaptability, which will also contribute to market growth. For instance, according to the study “Total laparoscopic hysterectomy with a newly designed uterine manipulator (Halder’s): Safety, efficacy and perforation prevention ” published in April 2020, the Halder’s uterine manipulator is an easy, smart and simple option to do TLH, which reduces the complications and have more favorable operative outcomes. This manipulator can be used by inexperienced persons at the vaginal end, thus, positively impacting the market growth.
The study “Laparoendoscopic Single Site Hysterectomy: Literature Review and Procedure Description,” published in April 2021, suggests that intra-uterine manipulator permits a better exposure of the pelvic field, helping the surgeon by exposing the correct surgical planes of the operative field. Thus, added advantages of uterine manipulators during TLH procedures will fuel the market growth.
- Thus, owing to the above-mentioned factors, the studied market is expected to grow significantly during the study period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
The primary driving factors for the growth of the North American uterine manipulator market are the rising burden of female reproductive system diseases such as cervical cancer, endometriosis, and others, rising demand for minimally invasive surgeries, and rising technological advancements.
The United States within North America contributes to the significant growth in the studied market. The rising burden of these diseases in the country will boost the market. For instance, according to a January 2022 update by the American Cancer Society, approximately 14,100 new cases of invasive cervical cancer will be diagnosed in 2022 in the country, with estimated 4,280 women deaths from the disease. Thus, the high prevalence and mortality rate associated with cervical cancer will boost its early treatment, thereby driving the demand for uterine manipulator devices as they are used for addressing cervical cancer, thus boosting the market.
The rising research and development studies in the market will also boost market growth. For instance, a prospective, multicenter, randomized non-inferiority phase III study was initiated in May 2021 to evaluate if patients undergoing a minimally invasive surgery for early-stage uterine cancer have cancer cells in the fluid that is obtained at the time of their surgery when a uterine manipulator is placed versus patients who do not have a uterine manipulator placed. Such studies will help in evaluating the efficacy and safety of the uterine manipulators, which can boost their adaptability; therefore, such studies might contribute to the market growth.
The article “For Early-Stage Cervical Cancer, Minimally Invasive Surgery Declining,” published by National Cancer Institute in May 2021, suggested that uterine manipulators are used during minimally invasive procedures to improve the surgeon’s ability to access and visualize the uterus and surrounding structures. Thus, as uterine manipulators assist surgeons during minimally invasive surgeries, the demand for the same is expected to grow during the study period, which will propel the market growth.
- Hence, owing to the above-mentioned factors, the studied market is expected to grow during the forecast period.
Competitive Landscape
The major players in the market are Conkin Surgical Instrument Ltd., CooperSurgical Inc., B. Braun Melsungen AG, KARL STORZ GmbH & Co. KG, CONMED Corporation, and others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION (Market Size by Value - USD Million)
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Conkin Surgical Instrument Ltd.
- CooperSurgical Inc.
- B. Braun Melsungen AG
- KARL STORZ GmbH & Co. KG
- CONMED Corporation
- RUDOLF Medical GmbH + Co. KG
- Richard Wolf GmbH
- Utah Medical Products, Inc.
- Purple Surgical
- Clinical Innovations, LLC
- Bissinger Medizintechnik
- LSI Solutions, Inc.
Methodology
LOADING...
